Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.4030
-0.0340 (-7.78%)
At close: Mar 31, 2025, 4:00 PM
0.4051
+0.0020 (0.51%)
Pre-market: Apr 1, 2025, 5:34 AM EDT

Ekso Bionics Holdings Stock Forecast

EKSO's stock price has decreased by -70.37% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Ekso Bionics Holdings stock have an average target of 5.00, with a low estimate of 1.00 and a high estimate of 9.00. The average target predicts an increase of 1,140.69% from the current stock price of 0.40.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $1.00 $5.00 $9.00 $9.00
Change +148.14% +1140.7% +2133.3% +2133.3%

Analyst Ratings

The average analyst rating for Ekso Bionics Holdings stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Lake Street
Lake Street
Strong Buy
Maintains
$2$1
Strong Buy Maintains $2$1 +148.14% Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +2,133.25% Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +2,133.25% Jan 14, 2025
Lake Street
Lake Street
Strong Buy
Maintains
$2.5$2
Strong Buy Maintains $2.5$2 +396.28% Oct 29, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$9
Strong Buy Maintains $10$9 +2,133.25% Oct 29, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
22.44M
from 17.93M
Increased by 25.17%
Revenue Next Year
30.74M
from 22.44M
Increased by 37.02%
EPS This Year
-0.33
from -0.56
EPS Next Year
-0.10
from -0.33
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
8.88M11.25M12.91M18.28M17.93M22.44M30.74M40.19M
Revenue Growth
-36.18%26.62%14.81%41.57%-1.94%25.17%37.02%30.73%
EPS
-2.21-0.88-1.16-1.10-0.56-0.33-0.100.12
EPS Growth
--------
Forward PE
-------3.29
No. Analysts -----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 25.2M 32.4M 41.4M
Avg 22.4M 30.7M 40.2M
Low 19.6M 28.8M 38.6M

Revenue Growth

Revenue Growth 202520262027
High
40.5%
44.5%
34.6%
Avg
25.2%
37.0%
30.7%
Low
9.3%
28.4%
25.6%

EPS Forecast

EPS 202520262027
High -0.26 - 0.13
Avg -0.33 -0.10 0.12
Low -0.38 -0.20 0.12

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.